Sprionaloctone

  Address - United Kingdom

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 104043708

  Document Type - Tender Notices

Description - Description: NHS England has published this Preliminary Market Engagement Notice for the Licence variation: spironolactone for acne in women. It is anticipated that there will be two separate contracts to deliver this, as outlined below. • Contract A: Prepare an application for a major (type II) MHRA Marketing Authorisation variation for spironolactone. • Contract B: Submit the pre-prepared application to the MHRA. Only current Marketing Authorisation Holders of spironolactone are eligible to bid for contract B. To register an interest in responding to this market engagement exercise and obtain a copy of the Request for Information documentation please go to: http://health.atamis.co.uk.

Gt Ref Id - 104043708

Deadline - Feb 26, 2026